Omeros (OMER) News Today $6.78 +0.02 (+0.30%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$6.45 -0.33 (-4.85%) As of 04/17/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Vanguard Group Inc. Reduces Stock Position in Omeros Co. (NASDAQ:OMER)Vanguard Group Inc. lowered its stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) by 3.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,141,657 shares of the biopharmaceutical company's stApril 16 at 3:12 AM | marketbeat.comD. Boral Capital Reaffirms Buy Rating for Omeros (NASDAQ:OMER)D. Boral Capital reissued a "buy" rating and set a $36.00 target price on shares of Omeros in a research report on Friday.April 13, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Earns "Buy" Rating from D. Boral CapitalApril 13, 2025 | americanbankingnews.comOmeros' New Leukemia Drug Team Ignites Hope For Cancer FightApril 11, 2025 | benzinga.comOmeros (NASDAQ:OMER) Rating Lowered to Sell at StockNews.comApril 11, 2025 | americanbankingnews.comOmeros Announces the Omeros Oncology Clinical Steering Committee for AML to Help Guide Omeros' Proprietary OncotoX-AML Clinical ProgramApril 10, 2025 | businesswire.comOmeros (NASDAQ:OMER) Downgraded by StockNews.com to SellStockNews.com cut shares of Omeros from a "hold" rating to a "sell" rating in a report on Wednesday.April 10, 2025 | marketbeat.comOmeros FY2025 EPS Estimate Decreased by Cantor FitzgeraldOmeros Co. (NASDAQ:OMER - Free Report) - Stock analysts at Cantor Fitzgerald cut their FY2025 earnings per share (EPS) estimates for Omeros in a report released on Wednesday, April 2nd. Cantor Fitzgerald analyst O. Brayer now expects that the biopharmaceutical company will post earnings of ($2.19April 6, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Shares Up 9.2% - Time to Buy?Omeros (NASDAQ:OMER) Trading Up 9.2% - What's Next?April 4, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Upgraded to Hold at StockNews.comStockNews.com raised Omeros from a "sell" rating to a "hold" rating in a research note on Tuesday.April 3, 2025 | marketbeat.comNeedham & Company LLC Reiterates "Hold" Rating for Omeros (NASDAQ:OMER)Needham & Company LLC reiterated a "hold" rating on shares of Omeros in a research report on Tuesday.April 3, 2025 | marketbeat.comOmeros Co. (NASDAQ:OMER) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Omeros Co. (NASDAQ:OMER - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five analysts that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and oApril 3, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Raised to Hold at StockNews.comStockNews.com raised Omeros from a "sell" rating to a "hold" rating in a report on Tuesday.April 3, 2025 | marketbeat.comOmeros reports Q4 EPS (54c), consensus (71c)April 2, 2025 | markets.businessinsider.comOmeros (NASDAQ:OMER) Announces Quarterly Earnings ResultsOmeros (NASDAQ:OMER - Get Free Report) released its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.54) earnings per share for the quarter, topping analysts' consensus estimates of ($0.71) by $0.17. During the same period in the previous year, the firm posted ($0.15) earnings per share.April 2, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Given "Buy" Rating at D. Boral CapitalD. Boral Capital reiterated a "buy" rating and set a $36.00 price objective on shares of Omeros in a research report on Tuesday.April 2, 2025 | marketbeat.comOmeros Corporation’s Earnings Call Highlights Progress and ChallengesApril 1, 2025 | tipranks.comOmeros Corporation (NASDAQ:OMER) Q4 2024 Earnings Call TranscriptApril 1, 2025 | msn.comOmeros Corp (OMER) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ...April 1, 2025 | gurufocus.comOmeros (OMER) Exceeds Q4 EPS Expectations, Reports Cash DeclineApril 1, 2025 | gurufocus.comQ4 2024 Omeros Corp Earnings Call TranscriptApril 1, 2025 | gurufocus.comOmeros Corporation (OMER) Q4 2024 Earnings Call TranscriptMarch 31, 2025 | seekingalpha.comOmeros Corporation Reports Fourth Quarter and Year-End 2024 Financial ResultsMarch 31, 2025 | businesswire.comOmeros Q4 2024 Earnings PreviewMarch 31, 2025 | seekingalpha.comOmeros (OMER) to Release Quarterly Earnings on MondayOmeros (NASDAQ:OMER) will be releasing earnings before the market opens on Monday, April 7, Financial Modeling Prep reports.March 31, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Trading Up 6.4% - What's Next?Omeros (NASDAQ:OMER) Shares Up 6.4% - Here's WhyMarch 28, 2025 | marketbeat.comTop Wall Street Forecasters Revamp Omeros Price Expectations Ahead Of Q4 EarningsMarch 28, 2025 | benzinga.comOmeros Corporation to Announce Fourth Quarter and Year-end Financial Results on March 31, 2025March 26, 2025 | investing.comOmeros to activate site for Phase III programme of zaltenibart for PNHMarch 24, 2025 | finance.yahoo.comOmeros provides update on zaltenibart trialMarch 22, 2025 | markets.businessinsider.comCorient Private Wealth LLC Has $7.25 Million Holdings in Omeros Co. (NASDAQ:OMER)Corient Private Wealth LLC trimmed its holdings in Omeros Co. (NASDAQ:OMER - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 733,449 shares of the biopharmaceutical company's stockMarch 22, 2025 | marketbeat.comOmeros (OMER) Expected to Announce Earnings on MondayOmeros (NASDAQ:OMER) will be releasing earnings after the market closes on Monday, March 24, Financial Modeling Prep reports.March 22, 2025 | marketbeat.comOmeros Corporation Provides Update of Ongoing Zaltenibart Phase 3 PNH Clinical Trial ProgramMarch 21, 2025 | businesswire.com113,326 Shares in Omeros Co. (NASDAQ:OMER) Acquired by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Omeros Co. (NASDAQ:OMER - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 113,326 shares of the biopharmaceutical coMarch 21, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Stock Rating Upgraded by StockNews.comStockNews.com raised shares of Omeros from a "sell" rating to a "hold" rating in a research note on Thursday.March 13, 2025 | marketbeat.comOmeros Co. (NASDAQ:OMER) Receives Consensus Recommendation of "Moderate Buy" from AnalystsOmeros Co. (NASDAQ:OMER - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five brokerages that are covering the stock, MarketBeat reports. Two research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy ratinMarch 8, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Lowered to Sell Rating by StockNews.comStockNews.com downgraded Omeros from a "hold" rating to a "sell" rating in a research note on Wednesday.March 6, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?Omeros (NASDAQ:OMER) Stock Passes Above 200-Day Moving Average - Here's WhyMarch 1, 2025 | marketbeat.comOmeros Corporation: Scientifically Compelling Again, But The Delay Has Cost UsFebruary 24, 2025 | seekingalpha.comINGALLS & SNYDER LLC Reduces Stake in Omeros Corp: A Strategic Portfolio AdjustmentFebruary 23, 2025 | gurufocus.comOmeros announces results for narsoplimab expanded access programFebruary 21, 2025 | finance.yahoo.comOmeros (NASDAQ:OMER) Given Buy Rating at D. Boral CapitalD. Boral Capital reaffirmed a "buy" rating and issued a $36.00 price objective on shares of Omeros in a research report on Thursday.February 21, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Trading Up 6.9% - Here's What HappenedOmeros (NASDAQ:OMER) Trading 6.9% Higher - Time to Buy?February 21, 2025 | marketbeat.comOmeros Announces Robust Results for Narsoplimab Expanded Access Program in TA-TMAFebruary 20, 2025 | uk.finance.yahoo.comOmeros (NASDAQ:OMER) Stock Crosses Above Two Hundred Day Moving Average - Time to Sell?Omeros (NASDAQ:OMER) Shares Cross Above Two Hundred Day Moving Average - Time to Sell?February 19, 2025 | marketbeat.comOmeros Co. (NASDAQ:OMER) Given Average Rating of "Moderate Buy" by AnalystsShares of Omeros Co. (NASDAQ:OMER - Get Free Report) have earned an average rating of "Moderate Buy" from the five analysts that are covering the firm, MarketBeat.com reports. Two analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy ratFebruary 11, 2025 | marketbeat.comInstitutions own 43% of Omeros Corporation (NASDAQ:OMER) shares but retail investors control 53% of the companyFebruary 10, 2025 | finance.yahoo.comOmeros Corporation Announces Upcoming Presentations Detailing Outcomes of Narsoplimab Treatment for TA-TMA Under an Expanded Access ProgramFebruary 10, 2025 | businesswire.com40,000 Shares in Omeros Co. (NASDAQ:OMER) Purchased by Stordahl Capital Management Inc.Stordahl Capital Management Inc. acquired a new stake in shares of Omeros Co. (NASDAQ:OMER - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 40,000 shares of the biopharmaJanuary 30, 2025 | marketbeat.comOmeros (NASDAQ:OMER) Trading Up 5.3% - Here's What HappenedOmeros (NASDAQ:OMER) Trading Up 5.3% - What's Next?January 27, 2025 | marketbeat.com Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address OMER Media Mentions By Week OMER Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OMER News Sentiment▼0.290.49▲Average Medical News Sentiment OMER News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OMER Articles This Week▼63▲OMER Articles Average Week Get Omeros News Delivered to You Automatically Sign up to receive the latest news and ratings for OMER and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PCRX News NKTR News ASMB News CPIX News LLY News JNJ News ABBV News MRK News PFE News BMY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OMER) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omeros Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omeros With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OMER Stock Free OMER Stock Alerts